CDTX
Price
$90.56
Change
+$5.80 (+6.84%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
2.29B
PALI
Price
$0.90
Change
+$0.13 (+16.88%)
Updated
Sep 26 closing price
Capitalization
8.37M
Interact to see
Advertisement

CDTX vs PALI

Header iconCDTX vs PALI Comparison
Open Charts CDTX vs PALIBanner chart's image
Cidara Therapeutics
Price$90.56
Change+$5.80 (+6.84%)
Volume$13.79K
Capitalization2.29B
Palisade Bio
Price$0.90
Change+$0.13 (+16.88%)
Volume$1.24M
Capitalization8.37M
CDTX vs PALI Comparison Chart in %
Loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PALI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDTX vs. PALI commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a Buy and PALI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (CDTX: $90.56 vs. PALI: $0.89)
Brand notoriety: CDTX and PALI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 165% vs. PALI: 21%
Market capitalization -- CDTX: $2.15B vs. PALI: $7.2M
CDTX [@Biotechnology] is valued at $2.15B. PALI’s [@Biotechnology] market capitalization is $7.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 0 FA rating(s) are green whilePALI’s FA Score has 1 green FA rating(s).

  • CDTX’s FA Score: 0 green, 5 red.
  • PALI’s FA Score: 1 green, 4 red.
According to our system of comparison, both CDTX and PALI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 4 TA indicator(s) are bullish while PALI’s TA Score has 3 bullish TA indicator(s).

  • CDTX’s TA Score: 4 bullish, 4 bearish.
  • PALI’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CDTX is a better buy in the short-term than PALI.

Price Growth

CDTX (@Biotechnology) experienced а +31.80% price change this week, while PALI (@Biotechnology) price change was +48.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($2.3B) has a higher market cap than PALI($8.37M). CDTX YTD gains are higher at: 236.905 vs. PALI (-45.564). PALI has higher annual earnings (EBITDA): -11.83M vs. CDTX (-208.92M). CDTX has more cash in the bank: 511M vs. PALI (5.42M). PALI has less debt than CDTX: PALI (338K) vs CDTX (2.33M). CDTX (0) and PALI (0) have equivalent revenues.
CDTXPALICDTX / PALI
Capitalization2.3B8.37M27,419%
EBITDA-208.92M-11.83M1,766%
Gain YTD236.905-45.564-520%
P/E RatioN/A0.02-
Revenue00-
Total Cash511M5.42M9,433%
Total Debt2.33M338K690%
FUNDAMENTALS RATINGS
CDTX vs PALI: Fundamental Ratings
CDTX
PALI
OUTLOOK RATING
1..100
191
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
31
Undervalued
PROFIT vs RISK RATING
1..100
77100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
3483
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PALI's Valuation (31) in the null industry is somewhat better than the same rating for CDTX (85) in the Biotechnology industry. This means that PALI’s stock grew somewhat faster than CDTX’s over the last 12 months.

CDTX's Profit vs Risk Rating (77) in the Biotechnology industry is in the same range as PALI (100) in the null industry. This means that CDTX’s stock grew similarly to PALI’s over the last 12 months.

CDTX's SMR Rating (97) in the Biotechnology industry is in the same range as PALI (100) in the null industry. This means that CDTX’s stock grew similarly to PALI’s over the last 12 months.

CDTX's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for PALI (83) in the null industry. This means that CDTX’s stock grew somewhat faster than PALI’s over the last 12 months.

CDTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as PALI (100) in the null industry. This means that CDTX’s stock grew similarly to PALI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDTXPALI
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 9 days ago
85%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 19 days ago
90%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PALI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HCI187.567.13
+3.95%
HCI Group
HLI205.970.70
+0.34%
Houlihan Lokey
NOEM10.20N/A
N/A
CO2 Energy Transition Corp
YDKG3.34-0.01
-0.30%
Yueda Digital Holding
ENSC2.24-0.02
-0.88%
Ensysce Biosciences

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with NBY. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then NBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
+6.84%
NBY - CDTX
93%
Closely correlated
+1.87%
NCNA - CDTX
93%
Closely correlated
+0.75%
TAOX - CDTX
93%
Closely correlated
+6.22%
BPTSY - CDTX
92%
Closely correlated
N/A
KPRX - CDTX
90%
Closely correlated
+1.09%
More

PALI and

Correlation & Price change

A.I.dvisor indicates that over the last year, PALI has been closely correlated with CDTX. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if PALI jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PALI
1D Price
Change %
PALI100%
+16.20%
CDTX - PALI
82%
Closely correlated
+6.77%
TAOX - PALI
81%
Closely correlated
+6.95%
NCNA - PALI
81%
Closely correlated
+0.75%
NBY - PALI
80%
Closely correlated
+2.34%
AGEN - PALI
80%
Closely correlated
+1.28%
More